Drugmakers Novo Nordisk and Pfizer raised their offers in the multibillion-dollar takeover battle for obesity-drug developer Metsera

2 days ago 2

The revised bids are the latest antithetic twist successful the combat betwixt large drugmakers implicit cause developer Metsera.